Rami Alrezk MD MS, FACP
Adrenal Disease, Parathyroid, Pituitary Disorders & Neuroendocrinology, Thyroid
CEO, Founder of California Endocrine Center
Join to view full profile
29995 Technology DrSte 305Murrieta, CA 92563
Phone+1 951-574-3636
Fax+1 800-515-1908
Dr. Alrezk is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rami Alrezk, based in Murrieta, CA, specializes in endocrinology with subspecialties in adrenal disease, parathyroid, pituitary disorders, neuroendocrinology, Diabetes, obesity and thyroid. He completed his medical degree at Damascus University, followed by numerous fellowships, including those at UCLA and the NIH. His career includes roles such as Clinical Director and Assistant Professor at the Cleveland Clinic, and he is currently the Founder and CEO of California Endocrine Center. Dr. Alrezk has published significant research in his field and has been recognized with honors such as the Fellowship of the American College of Physicians.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2016 - 2018
NIH Section on Neuroendocrinology Fellowship, Endocrine Tumors, Adrenal Tumors, Pheochromocytoma, Paraganlgioma, MEN1, MEN2, Pituitary Tumors., 2016 - 2018- University of California, Los AngelesMaster of Science in Clinical Research, Honors, 2014 - 2016
- UCLA- VA Research Fellowship Award MSCR, Clinical Research , Honors, 2013 - 2016
- Caltech Post-Doctoral Fellowship, 2013 - 2014
Certifications & Licensure
CA State Medical License 2011 - 2027
OH State Medical License 2018 - 2023
WY State Medical License 2021 - 2023
DC State Medical License 2016 - 2018
MD State Medical License 2017 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
National Board of Physicians and Surgeons Geriatric Medicine- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Sigma Xi nomination to full membership Sigma Xi, 2025
- Fellowship of the American College of Physicians American College of Physicians, 2013
- UCLA Graduate School Scholarship Division of Geriatrics, Department of Medicine, UCLA, 2013
Publications & Presentations
PubMed
- 46 citationsClinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma.Abhishek Jha, Kristine de Luna, Charlene Ann Balili, Corina Millo, Cecilia Angela Paraiso
Frontiers in Oncology. 2019-02-22 - 81 citationsUpdate of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging.Rami Alrezk, Andres Suarez, Isabel Tena, Karel Pacak
Frontiers in Endocrinology. 2018-11-27 - 32 citationsDerivation and Validation of a Geriatric-Sensitive Perioperative Cardiac Risk Index.Rami Alrezk, Nicholas Jackson, Mohanad Al Rezk, Robert Elashoff, Nancy Weintraub
Journal of the American Heart Association. 2017-11-01
Journal Articles
- Mucosal neuromas of tongue and lips: a diagnostic clue to MEN2BRami Alrezk, John Glod, Karel Pacak, BMJ, 8/3/2018
Books/Book Chapters
Press Mentions
Cardiovascular Risk Stratification for Older Adults Undergoing Cancer SurgeryMarch 1st, 2023
Cardiovascular Risk Stratification for Older Adults Undergoing Cancer Surgery: Don’t Call It Cardiac Clearance!February 15th, 2023
Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and ImagingNovember 28th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: